InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001477449-24-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-02 2024-02-02 TDOC Napolitano Richard J CAO S - Sale+OE $19.18 -872 11.7K -7% -$16.7K
D 2024-02-02 2024-02-01 TDOC Napolitano Richard J CAO M - OptEx — +2,020 12.6K +19% —
D 2024-02-02 2024-02-01 TDOC Napolitano Richard J CAO M - OptEx $0.00 -2,020 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-02 S D 872 $19.18 11,749 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2024-02-01 M A 2,020 — 12,621 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2024-02-01 M D 2,020 $0.00 0 D — · — to — 2,020 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.